FR2685917A1 - Nouveau derive de la pyridylsulfonyluree des procedes de preparation et les compositions pharmaceutiques le contenant. - Google Patents

Nouveau derive de la pyridylsulfonyluree des procedes de preparation et les compositions pharmaceutiques le contenant. Download PDF

Info

Publication number
FR2685917A1
FR2685917A1 FR9200031A FR9200031A FR2685917A1 FR 2685917 A1 FR2685917 A1 FR 2685917A1 FR 9200031 A FR9200031 A FR 9200031A FR 9200031 A FR9200031 A FR 9200031A FR 2685917 A1 FR2685917 A1 FR 2685917A1
Authority
FR
France
Prior art keywords
formula
compound
cycloheptylamino
pharmaceutically acceptable
pyrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9200031A
Other languages
English (en)
French (fr)
Other versions
FR2685917B1 (enExample
Inventor
Masereel
Pirotte Bernard
Schynts Marc
Delarge Jacques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Servier de Medecine Translationnelle SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Priority to FR9200031A priority Critical patent/FR2685917A1/fr
Priority to US07/825,142 priority patent/US5166162A/en
Priority to AU31015/93A priority patent/AU654607B2/en
Priority to CA002086698A priority patent/CA2086698A1/fr
Priority to EP93400003A priority patent/EP0551219A1/fr
Priority to US08/000,474 priority patent/US5391559A/en
Priority to ZA9364A priority patent/ZA9364B/xx
Priority to JP5000691A priority patent/JPH0684353B2/ja
Priority to NZ245619A priority patent/NZ245619A/en
Publication of FR2685917A1 publication Critical patent/FR2685917A1/fr
Application granted granted Critical
Publication of FR2685917B1 publication Critical patent/FR2685917B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
FR9200031A 1990-03-02 1992-01-06 Nouveau derive de la pyridylsulfonyluree des procedes de preparation et les compositions pharmaceutiques le contenant. Granted FR2685917A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR9200031A FR2685917A1 (fr) 1992-01-06 1992-01-06 Nouveau derive de la pyridylsulfonyluree des procedes de preparation et les compositions pharmaceutiques le contenant.
US07/825,142 US5166162A (en) 1990-03-02 1992-01-24 Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
CA002086698A CA2086698A1 (fr) 1992-01-06 1993-01-05 Derive de la pyridylsulfonyluree, ses procedes de preparation, et les compositions pharmaceutiques le contenant
EP93400003A EP0551219A1 (fr) 1992-01-06 1993-01-05 Nouveau dérivé de la pyridylsulfonylurée, ses procédés de préparation et les compositions pharmaceutiques le contenant
AU31015/93A AU654607B2 (en) 1992-01-06 1993-01-05 New pyridylsulphonylurea compound, processes for the preparation thereof, and pharmaceutical compositions containing it
US08/000,474 US5391559A (en) 1992-01-06 1993-01-05 New pyridylsulphonylurea compound
ZA9364A ZA9364B (en) 1992-01-06 1993-01-06 Pyridysulphonylure compound, processes for the preparation thereof, and pharmaceutical compositions containing it
JP5000691A JPH0684353B2 (ja) 1992-01-06 1993-01-06 新規ピリジルスルホニル尿素化合物
NZ245619A NZ245619A (en) 1992-01-06 1993-01-06 Substituted pyrid-3-yl sulphonylurea derivative, its preparation and pharmaceutical compositions thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9200031A FR2685917A1 (fr) 1992-01-06 1992-01-06 Nouveau derive de la pyridylsulfonyluree des procedes de preparation et les compositions pharmaceutiques le contenant.

Publications (2)

Publication Number Publication Date
FR2685917A1 true FR2685917A1 (fr) 1993-07-09
FR2685917B1 FR2685917B1 (enExample) 1995-06-02

Family

ID=9425396

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9200031A Granted FR2685917A1 (fr) 1990-03-02 1992-01-06 Nouveau derive de la pyridylsulfonyluree des procedes de preparation et les compositions pharmaceutiques le contenant.

Country Status (8)

Country Link
US (1) US5391559A (enExample)
EP (1) EP0551219A1 (enExample)
JP (1) JPH0684353B2 (enExample)
AU (1) AU654607B2 (enExample)
CA (1) CA2086698A1 (enExample)
FR (1) FR2685917A1 (enExample)
NZ (1) NZ245619A (enExample)
ZA (1) ZA9364B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559151A (en) * 1994-11-30 1996-09-24 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers
ITMI20022749A1 (it) * 2002-12-23 2004-06-24 Cosma S P A Nuovo procedimento per la sintesi della tosemide, in particolare della forma ii pura e stabile.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445039A1 (fr) * 1990-03-02 1991-09-04 Adir Et Compagnie Nouveaux dérivés de la pyridylsulfonylurée et de la pyridylsulfonylthiourée leur procédé de préparation et les compositions pharmaceutiques que les contiennent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445039A1 (fr) * 1990-03-02 1991-09-04 Adir Et Compagnie Nouveaux dérivés de la pyridylsulfonylurée et de la pyridylsulfonylthiourée leur procédé de préparation et les compositions pharmaceutiques que les contiennent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
S. BUDAVARI 'THE MERCK INDEX, 11TH EDITION' 1989 , MERCK & CO., INC. , RAHWAY, N.J. USA *

Also Published As

Publication number Publication date
EP0551219A1 (fr) 1993-07-14
ZA9364B (en) 1993-08-03
US5391559A (en) 1995-02-21
AU654607B2 (en) 1994-11-10
AU3101593A (en) 1993-07-08
NZ245619A (en) 1994-10-26
JPH061766A (ja) 1994-01-11
JPH0684353B2 (ja) 1994-10-26
CA2086698A1 (fr) 1993-07-07
FR2685917B1 (enExample) 1995-06-02

Similar Documents

Publication Publication Date Title
EP0580502B1 (fr) 3-(hydroxybenzylidényl)-indoline-2-ones, et les compositions pharmaceutiques qui les contiennent
EP0506539B1 (fr) Amides alkyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US8093260B2 (en) Aporphine derivatives and pharmaceutical use thereof
EP1373219A1 (fr) Thiohydantoines et leur utilisation dans le traitement du diabete
EP1720544B1 (fr) Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2663934A1 (fr) Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
EP0302980B1 (fr) 1,4-Dihydropyridines, leur procédé de préparation et leur application comme médicaments
CA2075017A1 (fr) Nouvelles (isoquinolein-5 yl) sulfamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0112191A1 (fr) Nouveaux dérivés du 4-(1H-indol-3-yl) alpha-méthylpipéridine 1-éthanol, leurs sels, le procédé de préparation, l'application à titre de médicaments et les compositions les renfermant
FR2556343A1 (fr) Nouveaux derives d'aminoguanidine, procede pour leur preparation et medicaments les contenant
EP1709027B1 (fr) Composes de type hydrazide et leur utilisation dans des compositions pharmaceutiques pour le traitement des maladies cardiovasculaires
EP0533516B1 (fr) Nouveaux composés amidiques des 1-(alcoxybenzyl) pipérazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent
EP0566446A1 (fr) Dérivés d'indane-1, 3-dione et d'indane-1,2,3-trione, leurs procédés de préparation et leur application en thérapeutique
FR2780404A1 (fr) Nouveaux derives de nitrone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0847999B1 (fr) Dérivés de N-benzylpipérazine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0551219A1 (fr) Nouveau dérivé de la pyridylsulfonylurée, ses procédés de préparation et les compositions pharmaceutiques le contenant
EP0395528A2 (fr) Dérivés du 4-phénylméthyl 1H-indole, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant.
EP0259206A1 (fr) Dérivés de la dihydro-1,4 pyridine leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
CA2629738C (fr) Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
WO1998025913A1 (fr) Nouveaux derives [3h]-benzoxazole-2-thiones et [3h]-benzothiazole-2-thiones substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CH624922A5 (en) Process for the preparation of new methylamine derivatives
EP1757586B1 (fr) Nouveaux composés 1,1-pyridinylaminocyclopropanamines polysubstitués, leur procédé de préparation et les compositions pharmaceutiques yui les contiennent
CA2648836A1 (fr) Nouveaux derives d'1h-indol-1-yl uree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0645375A1 (fr) Utilisation de dérivés de benzène-sulfonyl-indole pour la préparation de médicaments
FR3161349A1 (fr) Nouveaux inhibiteurs des transporteurs de cations organiques pour le traitement des troubles de l’humeur

Legal Events

Date Code Title Description
ST Notification of lapse